Tag Archives: Oral

Pancreatic cancer, known as a “silent killer” that mostly creeps in quietly with hard-to-detect symptoms, remains a significant global health challenge. With 508,533 new cases and 505,752 deaths worldwide in 2021, this disease is a significant global health challenge with increasing incidence and mortality rates worldwide.World Alzheimer’s Day 2025: The first signs families often missPancreatic cancer is often considered deadly …

Under brand names like Wegovy and Ozempic, semaglutide assists weight loss and manages diabetes through a series of daily injections. Unfortunately, the small sting that’s required with every dose can dissuade many from considering the medication as an option. A new clinical trial suggests a pill form could soon be a viable alternative. Semaglutide is currently administered through a weekly …

Lilly’s oral GLP-1, orforglipron, superior to oral semaglutide in head-to-head trial  Eli Lilly and Company Eli Lilly’s obesity pill outperforms Novo Nordisk’s oral drug in head-to-head diabetes trial  CNBC Daily weight loss pill can help cut body weight by a fifth, trial shows  The Guardian Lilly’s Obesity Pill Will Have Far-Reaching Effect, Doctors Say  Bloomberg.com Lilly weight-loss pill could be FDA-approved by year-end  Reuters Source …

Photo by Alex Lvrs (cropped) The blood pressure lowering effect of nitrate-rich beetroot juice in older people may be due to specific changes in their oral microbiome, according to the largest study of its kind. Researchers at the University of Exeter in England conducted the study which was published in the journal Free Radical Biology and Medicine. It followed previous …

Lilly’s oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity  Eli Lilly and Company Eli Lilly’s weight loss pill orforglipron clears its latest trial, paving way for approval  CNBC Eli Lilly Ready to Seek Obesity Pill Green Light After Study Hits Goals  The Wall Street Journal Eli Lilly’s weight-loss pill meets …

Twenty years ago, chest hair was ripped, improv was maximized, and a V-card was taken. Here is the story of the movie that kicked off a golden age of raunchy bro comedies. Twenty years ago, chest hair was ripped, improv was maximized, and a V-card was taken. Here is the story of the movie that kicked off a golden age …

A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Eli Lilly‘s stock is still recovering after the drugmaker released trial data earlier this month on its closely watched obesity pill that underwhelmed Wall Street. In a key late-stage trial, Eli Lilly’s pill, orforglipron, caused …

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud. You can reach Allison on Signal at AllisonDeAngelis.01. A new oral weight loss drug developed by Viking Therapeutics hit the mark in a mid-stage clinical trial, but the …

Key Takeaways Viking Therapeutics reported a large number of patients dropped out of a study of its experimental weight-loss pill. Overall, 28% of those taking VK2735 left the Phase 2 trial early compared with 18% among placebo subjects. The research showed the pill reduced the weight of patients who took it for 13 weeks by up to 26.7 pounds. Viking …

Viking Therapeutics loses a third of its value after oral weight-loss drug trial  MarketWatch Viking Therapeutics shares fall 40% on disappointing obesity pill trial data  CNBC Viking Therapeutics (VKTX) Stock Fell More Than 30%. What Sent It Crashing.  Barron’s Viking’s oral pill reduces up to 12.2% weight but shares slump on higher patient exits  Reuters Viking Therapeutics Rises as Phase 3 Trials and Oral …